Dr Mark Trozzi（マーク・トロッツィ博士）がCOVID-19 mRNAワクチンによる障害報告に関する査読済み論文の約1,000件を掲載したサイトを作っています。
1000 peer reviewed articles on “Vaccine” injuries
その中で6番目に多くの件数が報告されている「ギラン・バレー症候群（Guillain-Barre Syndrome;GBS）」の論文リストを転載させていただきます。
体の免疫系が誤って末梢神経系（脳と脊髄の外側にある神経のネットワーク）の一部を攻撃する神経疾患。GBSは、短時間の脱力感を伴うごく軽症のものから、ほとんど壊滅的な麻痺を引き起こし、独立して呼吸することができなくなるものまである。幸いなことに、GBSの重症例であっても、ほとんどの人は最終的に回復する。回復後も、ある程度の脱力が続く人もいます。
掲載論文数: 43
GM1 ganglioside antibody and COVID-19-related Guillain Barre syndrome: case report, systemic review, and implications for vaccine development:
https://www.sciencedirect.com/science/article/pii/S2666354621000065
Guillain-Barre syndrome after AstraZeneca COVID-19 vaccination: causal or casual association:
https://www.sciencedirect.com/science/article/pii/S0303846721004169
Sensory Guillain-Barre syndrome after ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature:
https://www.sciencedirect.com/science/article/pii/S0165572821002186
Guillain-Barre syndrome after thefirst dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association:
https://www.sciencedirect.com/science/article/pii/S2214250921000998
Guillain-Barre syndrome presenting as facial diplegia after vaccination with COVID-19: a case report:
https://www.sciencedirect.com/science/article/pii/S0736467921006442
Guillain-Barre syndrome after thefirst injection of ChAdOx1 nCoV-19 vaccine: first report:
https://www.sciencedirect.com/science/article/pii/S0035378721005853
SARS-CoV-2 vaccines are not safe for those with Guillain-Barre syndrome following vaccination: https://www.sciencedirect.com/science/article/pii/S2049080121005343
Guillian Barre syndrome after vaccination with mRNA-1273 against COVID-19
https://pubmed.ncbi.nlm.nih.gov/34477091/
A novel case of bifacial diplegia variant of Guillain-Barre syndrome after vaccination with Janssen COVID-19
https://pubmed.ncbi.nlm.nih.gov/34449715/
Sensory Guillain-Barre syndrome following ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature:
https://pubmed.ncbi.nlm.nih.gov/34416410/
Facial diplegia: a rare and atypical variant of Guillain-Barre syndrome and the Ad26.COV2.S vaccine: https://pubmed.ncbi.nlm.nih.gov/34447646/
Guillain-Barre syndrome after ChAdOx1 nCoV-19 COVID-19 vaccination: a case series:
https://pubmed.ncbi.nlm.nih.gov/34548920/
AstraZeneca COVID-19 vaccine and Guillain-Barre syndrome in Tasmania: a causal link:
https://pubmed.ncbi.nlm.nih.gov/34560365/
COVID-19, Guillain-Barre and vaccineA dangerous mix:
https://pubmed.ncbi.nlm.nih.gov/34108736/
Guillain-Barre syndrome after the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases:
https://pubmed.ncbi.nlm.nih.gov/34796417/
Guillain-Barre syndrome after BNT162b2 COVID-19 vaccine:
https://link.springer.com/article/10.1007%2Fs10072-021-05523-5
COVID-19 adenovirus vaccines and Guillain-Barre syndrome with facial palsy:
https://onlinelibrary.wiley.com/doi/10.1002/ana.26258
Association of receipt association of Ad26.COV2.S COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021:
https://jamanetwork.com/journals/jama/fullarticle/2785009
A case of Guillain-Barre syndrome after P? zer COVID-19vaccine:
https://pubmed.ncbi.nlm.nih.gov/34567447/
Guillain-Barre syndrome associated with COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34648420/
Rate of recurrent Guillain-Barre syndrome after COVID-19 BNT162b2 mRNA vaccine:
https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708
Guillain-Barre syndrome after COVID-19 vaccination in an adolescent:
https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext
Guillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34114256/
Guillain-Barre syndrome after COVID-19 mRNA-1273 vaccine: case report:
https://pubmed.ncbi.nlm.nih.gov/34767184/
Guillain-Barre syndrome following SARS-CoV-2 vaccination in 19 patients:
https://pubmed.ncbi.nlm.nih.gov/34644738/
Guillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients:
https://pubmed.ncbi.nlm.nih.gov/34649856/
A rare case of Guillain-Barre syndrome after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34671572/
Neurological complications of COVID-19: Guillain-Barre syndrome after Pfizer COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33758714/
COVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effect:
https://pubmed.ncbi.nlm.nih.gov/34484780/
Guillain-Barre syndrome after thefirst dose of COVID-19 vaccination: case report;
https://pubmed.ncbi.nlm.nih.gov/34779385/
Guillain-Barre syndrome after thefirst injection of ChAdOx1 nCoV-19 vaccine: first report:
https://pubmed.ncbi.nlm.nih.gov/34217513/
A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies after? rst dose of COVID-19 BNT162b2 mRNA vaccine (Pfizer):
https://pubmed.ncbi.nlm.nih.gov/34871447/
A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN:
https://pubmed.ncbi.nlm.nih.gov/34370408/
A rare variant of Guillain-Barre syndrome after vaccination with Ad26.COV2.S:
https://pubmed.ncbi.nlm.nih.gov/34703690/
Guillain-Barre syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barre syndrome:
https://pubmed.ncbi.nlm.nih.gov/34810163/
Guillain-Barre syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-2 vaccines: https://onlinelibrary.wiley.com/doi/10.1002/ana.26218
Variant Guillain-Barre syndrome occurring after SARS-CoV-2 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34114269/
Guillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-2 mRNA-based vaccine:
https://pubmed.ncbi.nlm.nih.gov/34722067/
Guillain-Barre syndrome after the? rst dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association:
https://pubmed.ncbi.nlm.nih.gov/33968610/
SARS-CoV-2 vaccines can be complicated not only by Guillain-Barre syndrome but also by distal small fiber neuropathy:
https://pubmed.ncbi.nlm.nih.gov/34525410/
Clinical variant of Guillain-Barre syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine:
https://pubmed.ncbi.nlm.nih.gov/34808658/
Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-2 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34848426/
Bilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine:
https://pubmed.ncbi.nlm.nih.gov/34261746/
